Nonprofit · EIN 80-0631734
NEW YORK GENOME CENTER INC
Tax-exempt · NEW YORK, NY 10013
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $82,342,631 | $84,343,480 | -$2,000,849 | $166,954,755 | $123,038,215 | $43,916,540 |
| December 31, 2023 | 990 | $92,940,429 | $81,872,824 | $11,067,605 | $184,052,230 | $138,136,156 | $45,916,074 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $75,537,348
- of which government grants
- $22,350,611
- Membership dues
- $2,435,000
- Program service revenue
- $4,904,919
- Investment income
- $360,077
- Royalties
- $1,683,278
- Net rental income
- -$865,077
- Net gain from sales of assets
- $259,206
- Other revenue
- $1,540,287
Expenses
- Grants and similar amounts paid
- $2,986,182
- Compensation of officers, directors and key employees
- $4,365,188
- Other salaries and wages
- $25,603,693
- Salaries, compensation and benefits (total)
- $37,954,307
- Professional fundraising fees
- $788
- Legal fees
- $455,423
- Accounting fees
- $141,144
- Occupancy
- $13,258,040
- Travel
- $457,045
- Depreciation
- $6,565,363
- Program services (functional)
- $68,153,855
- Management and general (functional)
- $14,860,197
- Fundraising (functional)
- $1,329,428
Balance sheet and other
- Total assets, start of year
- $184,052,230
- Total assets, end of year
- $166,954,755
- Total liabilities, end of year
- $123,038,215
- Net assets, end of year
- $43,916,540
- Land, buildings and equipment
- $43,485,057
- Net assets without donor restrictions
- $14,697,417
- Net assets with donor restrictions
- $29,219,123
- Gross unrelated business income
- $816,492
- Gross receipts
- $87,771,537
- Employees
- 284
- Volunteers
- 27
- Year formed
- 2010
- State of legal domicile
- DE
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| TOM MANIATIS PHD | SCIENTIFIC DIRECTOR & CEO Trustee or director, Officer | 40 | $675,040 | $0 |
| SARAH LESSER AVINS | SVP, ADVANCEMENT & CHIEF D Key employee | 40 | $566,991 | $38,719 |
| ELIZABETH BROOKS O'BRIEN | VP & GENERAL COUNSEL Officer | 40 | $468,516 | $46,016 |
| SOREN GERMER | SVP, GENOME TECHNOLOGIES Key employee | 40 | $439,717 | $38,719 |
| CAROL ASHE | CHIEF BUSINESS OFFICER Key employee | 40 | $438,815 | $20,817 |
| MARIA JOANTA | CHIEF FINANCIAL OFFICER Officer | 40 | $385,785 | $51,441 |
| MICHAEL CHARLES ZODY | SCIENTIFIC DIR, COMP BIOLO Key employee | 40 | $371,713 | $30,204 |
| THOMAS LEHNER | SCI DIR, NEURO DG (THROUGH 11/24) Key employee | 40 | $372,482 | $28,896 |
| CHARLES GAGNON | CHIEF INFORMATION OFFICER Key employee | 40 | $341,546 | $49,771 |
| SHAILAJA GARGEYA | SENIOR DIR, SOFTWARE ENGIN Highest-paid employee | 40 | $349,593 | $20,440 |
| DAYNA M OSCHWALD | CHIEF OF STAFF Highest-paid employee | 40 | $294,329 | $35,757 |
| CHRISTOPHER PHIFER BLACK | SR. DIR., RESEARCH COMP. Highest-paid employee | 40 | $263,806 | $45,444 |
| AVINASH VIJAY ABHYANKAR | DIRECTOR, CLINICAL BIOINFORM. Highest-paid employee | 40 | $259,321 | $41,952 |
| CATHERINE E REEVES | SR. DIR., SEQUENCING OPERATIONS Highest-paid employee | 40 | $241,489 | $36,532 |
| RUSSELL L CARSON MBA | DIRECTOR & CHAIRMAN Trustee or director, Officer | 1 | $0 | $0 |
25 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| IVAN G SEIDENBERG MBA | DIRECTOR & CO-CHAIR Trustee or director, Officer | 1 | $0 |
| HERB PARDES MD | DIR. & EXEC. VICE CHAIR (ENDED 4/24) Trustee or director | 1 | $0 |
| BRUCE STILLMAN PHD | DIRECTOR Trustee or director | 1 | $0 |
| KATRINA ARMSTRONG MD | DIRECTOR Trustee or director | 1 | $0 |
| SELWYN M VICKERS MD | DIRECTOR Trustee or director | 1 | $0 |
| DENNIS S CHARNEY MD | DIRECTOR Trustee or director | 1 | $0 |
| DAFNA BAR-SAGI PHD | DIRECTOR Trustee or director | 1 | $0 |
| KEVIN J TRACEY MD | DIRECTOR Trustee or director | 1 | $0 |
| KENNETH A DILL PHD | DIRECTOR (ENDED 10/24) Trustee or director | 1 | $0 |
| RICHARD P LIFTON MD PHD | DIRECTOR Trustee or director | 1 | $0 |
| BARBARA ROSATI PHD | DIRECTOR (STARTED 10/24) Trustee or director | 1 | $0 |
| ROBERT A HARRINGTON MD | DIRECTOR Trustee or director | 1 | $0 |
| ELI CASDIN | DIRECTOR Trustee or director | 1 | $0 |
| NICHOLAS DONOFRIO | DIRECTOR Trustee or director | 1 | $0 |
| JOSEPH E EDELMAN | DIRECTOR Trustee or director | 1 | $0 |
| JOHN B EHRENKRANZ | DIRECTOR Trustee or director | 1 | $0 |
| ANTHONY B EVNIN PHD | DIRECTOR Trustee or director | 1 | $0 |
| JOHN P HAVENS | DIRECTOR Trustee or director | 1 | $0 |
| WESLIE R JANEWAY | DIRECTOR Trustee or director | 1 | $0 |
| ALONDRA NELSON PHD | DIRECTOR (STARTED 6/24) Trustee or director | 1 | $0 |
| FRANK V SICA | DIRECTOR & COMMITTEE CHAIR Trustee or director | 1 | $0 |
| DAVID N SPERGEL PHD | DIRECTOR (STARTED 3/24) Trustee or director | 1 | $0 |
| JIM SIMONS PHD | DIRECTOR (THROUGH 5/24) Trustee or director | 1 | $0 |
| NANCY A THORNBERRY | DIRECTOR Trustee or director | 1 | $0 |
| STEVEN J CORWIN MD | DIRECTOR (STARTED 6/24) Trustee or director | 1 | $0 |
990 for the year ended December 31, 2023: 39 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| TOM MANIATIS PHD | SCIENTIFIC DIRECTOR & CEO Trustee or director, Officer | 40 | $659,380 | $0 |
| SARAH LESSER AVINS | SVP, ADVANCEMENT & CHIEF D Key employee | 40 | $564,596 | $37,074 |
| ELIZABETH BROOKS O'BRIEN | VP & GENERAL COUNSEL Officer | 40 | $466,101 | $44,808 |
| SOREN GERMER | SVP, GENOME TECHNOLOGIES Key employee | 40 | $437,568 | $37,446 |
| CAROL ASHE | CHIEF BUSINESS OFFICER Key employee | 40 | $436,587 | $19,917 |
| THOMAS LEHNER | SCI DIR, NEURO DIS GEN Key employee | 40 | $404,554 | $33,760 |
| MARIA JOANTA | CHIEF FINANCIAL OFFICER Officer | 40 | $385,336 | $49,938 |
| MICHAEL CHARLES ZODY | SCIENTIFIC DIR, COMP BIOLO Key employee | 40 | $369,902 | $29,110 |
| CHARLES GAGNON | CHIEF INFORMATION OFFICER Key employee | 40 | $344,112 | $49,131 |
| SHAILAJA GARGEYA | SENIOR DIR, SOFTWARE ENGIN Highest-paid employee | 40 | $332,688 | $19,917 |
| DAYNA M OSCHWALD | CHIEF OF STAFF Highest-paid employee | 40 | $282,476 | $33,972 |
| CHRISTOPHER PHIFER BLACK | SENIOR DIRECTOR, RESEARCH Highest-paid employee | 40 | $255,308 | $44,331 |
| CATHERINE E REEVES | SENIOR DIRECTOR, RESEARCH Highest-paid employee | 40 | $243,210 | $32,796 |
| HANNAH GOULDING | SENIOR DIRECTOR, HUMAN RES Highest-paid employee | 40 | $245,119 | $14,824 |
| RUSSELL L CARSON MBA | DIRECTOR & CHAIRMAN Trustee or director, Officer | 1 | $0 | $0 |
| IVAN G SEIDENBERG MBA | DIRECTOR & CO-CHAIR Trustee or director, Officer | 1 | $0 | $0 |
| HERB PARDES MD | DIRECTOR & EXEC. VICE CHAI Trustee or director | 1 | $0 | $0 |
| GORDON F TOMASELLI MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| BRUCE STILLMAN PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| KATRINA ARMSTRONG MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| SELWYN VICKERS MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DENNIS S CHARNEY MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DAFNA BAR-SAGI PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| KEVIN J TRACEY MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| KENNETH A DILL PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| RICHARD P LIFTON MD PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ROBERT HARRINGTON MD | DIRECTOR (AS OF 10/23) Trustee or director | 1 | $0 | $0 |
| FRANCIS LEE MD PHD | DIRECTOR (3/23 TO 10/23) Trustee or director | 1 | $0 | $0 |
| AUGUSTINE M K CHOI MD | DIRECTOR (THRU 3/23) Trustee or director | 1 | $0 | $0 |
| ELI CASDIN | DIRECTOR Trustee or director | 1 | $0 | $0 |
| NICHOLAS DONOFRIO | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOSEPH E EDELMAN | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN B EHRENKRANZ | DIRECTOR Trustee or director | 1 | $0 | $0 |
| ANTHONY B EVNIN PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| JOHN P HAVENS | DIRECTOR Trustee or director | 1 | $0 | $0 |
| WESLIE R JANEWAY | DIRECTOR Trustee or director | 1 | $0 | $0 |
| FRANK V SICA | DIRECTOR & COMMITTEE CHAIR Trustee or director | 1 | $0 | $0 |
| JIM SIMONS PHD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| NANCY THORNBERRY | DIRECTOR Trustee or director | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 101 AVENUE OF AMERICAS 7TH FLOOR, NEW YORK, NY 10013-0000
- In care of
- % NANCY KONG
- Principal officer (990 for 2024)
- TOM MANIATIS, 101 AVE OF THE AMERICAS, NEW YORK, NY 10013
- Signed the 990
- NANCY KONG, INTERIM CFO
- Phone
- (646) 977-7000
- Website
- WWW.NYGENOME.ORG
- Return prepared by
- KPMG LLP
Mission
OPERATE A STATE-OF-THE-ART, WORLD-CLASS GENOMIC RESEARCH CENTER THAT CREATES AND USES ADVANCED GENOMICS TO UNDERSTAND THE GENETIC BASIS OF DISEASE. FOR MORE INFORMATION, SEE SCHEDULE O.
Program accomplishments
- GENOME SEQUENCING: THE NEW YORK GENOME CENTER (NYGC) HAS ONE OF NEW YORK'S LARGEST AND MOST ADVANCED WHOLE GENOME SEQUENCING PROGRAMS, HAVING SEQUENCED OVER 106,885 WHOLE GENOME SAMPLES TO DATE. NYGC'S TWO STATE-OF-THE-ART ILLUMINA NOVASEQ X SYSTEMS SEQUENCERS ARE EACH CAPABLE OF SEQUENCING 20,000 HUMAN GENOMES ANNUALLY. THIS STATE-OF-THE-ART SEQUENCING TECHNOLOGY ENABLES NYGC TO CONDUCT LARGE-SCALE GENOMICS PROJECTS WITH GREAT SPEED AND SAMPLE VOLUMES, AND TO EXPLORE THE GENOME IN MORE DEPTH WITH GREATER EFFICIENCY. IN ADDITION, NYGC OPERATES AN OXFORD NANOPORE PROMETHION SEQUENCER FOR LONG READ SEQUENCING, AND A HIGH-THROUGHPUT SEQUENCER FROM ULTIMA GENOMICS (THE UG100). SEE SCHEDULE O.Expenses $60,479,500 · grants $2,986,182 · revenue $4,233,105
- CLINICAL SEQUENCING: NYGC'S CLEP/CLIA CERTIFIED CLINICAL LABORATORY IS AUTHORIZED BY THE NEW YORK STATE DEPARTMENT OF HEALTH TO OFFER THE FOLLOWING APPROVED CLINICAL TESTS: CONSTITUTIONAL WHOLE GENOME SEQUENCING FOR UNDIAGNOSED DISEASE, CONSTITUTIONAL WHOLE GENOME SEQUENCING FOR PREDISPOSITIONAL GENETIC SCREENING, ONCOLOGY WHOLE GENOME AND TRANSCRIPTOME SEQUENCING, TARGETED VARIANT TESTING USING SANGER SEQUENCING, MATERNAL CELL CONTAMINATION TESTING, AND ANEUPLOIDY SCREENING.Expenses $7,674,355 · revenue $671,814
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 80-0631734
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2012
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Health care (E22)
- Assets (IRS master file)
- $166,954,755
- Income (IRS master file)
- $87,771,537
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $82,342,631 | $84,343,480 | $166,954,755 | IRS |
| 990-T | December 2024 | – | – | – | IRS |
| 990 | December 2023 | $92,940,429 | $81,872,824 | $184,052,230 | XML |
| 990-T | December 2023 | – | – | – | IRS |
| 990 | December 2022 | $67,901,686 | $72,195,873 | $181,740,451 | IRS |
| 990-T | December 2022 | – | – | – | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990-T | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990-T | December 2020 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 80-0631734).
Questions about NEW YORK GENOME CENTER INC
- What is the EIN of NEW YORK GENOME CENTER INC?
- The employer identification number (EIN) of NEW YORK GENOME CENTER INC is 80-0631734.
- Is NEW YORK GENOME CENTER INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2012.
- Are donations to NEW YORK GENOME CENTER INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does NEW YORK GENOME CENTER INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of NEW YORK GENOME CENTER INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did NEW YORK GENOME CENTER INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of NEW YORK GENOME CENTER INC?
- The 990 for the year ended December 31, 2024 names TOM MANIATIS.
- Who are the officers and directors of NEW YORK GENOME CENTER INC?
- The 990 for the year ended December 31, 2024 lists 40 people; 14 received compensation from the organization, the highest $675,040 (TOM MANIATIS PHD, SCIENTIFIC DIRECTOR & CEO).
- How much revenue does NEW YORK GENOME CENTER INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $82,342,631, expenses of $84,343,480 and total assets of $166,954,755 at year end.
Other nonprofits in NEW YORK
- HEALTHFIRST PHSP INC EIN 13-3783732 · last filed 990 for 2024
- THE NEW YORK AND PRESBYTERIAN HOSPITAL EIN 13-3957095 · last filed 990 for 2024
- NYU LANGONE HOSPITALS EIN 13-3971298 · last filed 990 for 2025
- MEMORIAL SLOAN-KETTERING CANCER CENTER EIN 91-2154267 · last filed 990 for 2024
- METROPLUS HEALTH PLAN INC EIN 13-4115686 · last filed 990 for 2024
- HEALTH INSURANCE PLAN OF GREATER NEW YORK EIN 13-1828429 · last filed 990 for 2024
- MOUNT SINAI HOSPITAL EIN 13-1624096 · last filed 990 for 2024
- VNS CHOICE EIN 13-3951057 · last filed 990 for 2024